These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 26125420)

  • 1. Sentinel Node Biopsy After Neoadjuvant Chemotherapy: Prechemotherapy Nodal Status Is Crucial for Test Performance.
    Piana de Andrade V; Lordello de Melo L; Aparecida Bueno de Toledo Osório C; Andrade WP
    Arch Pathol Lab Med; 2015 Jul; 139(7):845. PubMed ID: 26125420
    [No Abstract]   [Full Text] [Related]  

  • 2. In Reply.
    Elliott RM; Shenk RR; Thompson CL; Gilmore HL
    Arch Pathol Lab Med; 2015 Jul; 139(7):845-6. PubMed ID: 26125421
    [No Abstract]   [Full Text] [Related]  

  • 3. Touch preparations for the intraoperative evaluation of sentinel lymph nodes after neoadjuvant therapy have high false-negative rates in patients with breast cancer.
    Elliott RM; Shenk RR; Thompson CL; Gilmore HL
    Arch Pathol Lab Med; 2014 Jun; 138(6):814-8. PubMed ID: 24878021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The feasibility and the role of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer].
    Péley G; Török K; Farkas E; Mátrai Z; Horváth Z; Sinkovics I; Hitre E; Rényi-Vámos F; Orosz Z; Köves I
    Magy Onkol; 2006; 50(1):19-23. PubMed ID: 16617379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refining the Performance of Sentinel Lymph Node Biopsy Post-neoadjuvant Chemotherapy in Patients with Pathologically Proven Pre-treatment Node-positive Breast Cancer: An Update for Clinical Practice.
    El Hage Chehade H; Headon H; Kasem A; Mokbel K
    Anticancer Res; 2016 Apr; 36(4):1461-71. PubMed ID: 27069121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast conservation and sentinel lymph node biopsy after neoadjuvant systemic therapy.
    Veronesi P; Gentilini O; Fernandez JR; Magnoni F
    Breast; 2009 Oct; 18 Suppl 3():S90-2. PubMed ID: 19914551
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer].
    Mátrai Z; Tóth L; Polgár C; Láng I; Gõdény M; Sinkovics I; Horváth Z; Bidlek M; Udvarhelyi N; Bartal A; Sávolt A; Ujhelyi M; Kásler M
    Magy Onkol; 2011 Jun; 55(2):73-84. PubMed ID: 21655472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel node biopsy before neoadjuvant chemotherapy spares breast cancer patients axillary lymph node dissection.
    van Rijk MC; Nieweg OE; Rutgers EJ; Oldenburg HS; Olmos RV; Hoefnagel CA; Kroon BB
    Ann Surg Oncol; 2006 Apr; 13(4):475-9. PubMed ID: 16485148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast.
    Schwartz GF; Tannebaum JE; Jernigan AM; Palazzo JP
    Cancer; 2010 Mar; 116(5):1243-51. PubMed ID: 20087958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can regional tattoos impact sentinel lymph node identification?
    Datrice N; Wirth G; Hsiang D; Butler J; Lane KT
    Am Surg; 2013 Mar; 79(3):331-2. PubMed ID: 23461966
    [No Abstract]   [Full Text] [Related]  

  • 11. Sentinel lymph node biopsy after neoadjuvant systemic chemotherapy in patients with breast cancer: a prospective pilot trial.
    Medina-Franco H; Salgado-Nesme N; Zerón-Medina-Cuairán J
    Rev Invest Clin; 2008; 60(5):390-4. PubMed ID: 19227436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolving the controversies surrounding lymphatic mapping in breast cancer.
    Bergkvist L
    Future Oncol; 2008 Oct; 4(5):681-8. PubMed ID: 18922125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axillary and internal mammary sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy.
    Cao XS; Li HJ; Cong BB; Sun X; Qiu PF; Liu YB; Wang CJ; Wang YS
    Oncotarget; 2016 Nov; 7(45):74074-74081. PubMed ID: 27738336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymph node biopsy is a reliable method for lymph node evaluation in neoadjuvant chemotherapy-treated patients with breast cancer.
    Koslow SB; Eisenberg RE; Qiu Q; Chen Z; Swistel A; Shin SJ
    Am Surg; 2014 Feb; 80(2):171-7. PubMed ID: 24480218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node wire localization post-chemotherapy: Towards improving the false negative sentinel lymph node biopsy rate in breast cancer patients.
    Dashevsky BZ; Altman A; Abe H; Jaskowiak N; Bao J; Schacht DV; Sheth D; Kulkarni K
    Clin Imaging; 2018; 48():69-73. PubMed ID: 29035756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel lymph node biopsy using periareolar injection of radiocolloid for patients with neoadjuvant chemotherapy-treated breast carcinoma.
    Shimazu K; Tamaki Y; Taguchi T; Akazawa K; Inoue T; Noguchi S
    Cancer; 2004 Jun; 100(12):2555-61. PubMed ID: 15197796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer.
    Zetterlund LH; Frisell J; Zouzos A; Axelsson R; Hatschek T; de Boniface J; Celebioglu F
    Breast Cancer Res Treat; 2017 May; 163(1):103-110. PubMed ID: 28224384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel lymph node biopsy after neo-adjuvant chemotherapy in patients with breast cancer: Are the current false negative rates acceptable?
    Patten DK; Zacharioudakis KE; Chauhan H; Cleator SJ; Hadjiminas DJ
    Breast; 2015 Aug; 24(4):318-20. PubMed ID: 25800381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer. Its relation with molecular subtypes].
    Ruano R; Ramos M; García-Talavera JR; Ramos T; Rosero AS; González-Orus JM; Sancho M
    Rev Esp Med Nucl Imagen Mol; 2014; 33(6):340-5. PubMed ID: 24856234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of sentinel lymph node biopsy in breast cancer women N1-N2 with complete axillary response after neoadjuvant chemotherapy. Multicentre study in Tarragona.
    Carrera D; de la Flor M; Galera J; Amillano K; Gomez M; Izquierdo V; Aguilar E; López S; Martínez M; Martínez S; Serra JM; Pérez M; Martin L
    Rev Esp Med Nucl Imagen Mol; 2016; 35(4):221-5. PubMed ID: 26848141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.